RecruitingNCT07456696
TSND-201 for post-traumatic stress symptoms in adults
About this title
Read the official source — NCT07456696Researchers are comparing TSND-201 and placebo to find out how the approaches affect post-traumatic stress symptoms in people with PTSD.
Medication studyAges 18+United States
Understand this study
What is this study about?
Researchers are comparing TSND-201 and placebo to find out how the approaches affect post-traumatic stress symptoms in people with PTSD.
Who could participate?
This study is for people with PTSD. Listed age limits: from 18 years. Other eligibility criteria apply.
What will I do during this study?
You are randomly assigned to one of three groups: one of two TSND-201 dose groups or placebo (an inactive comparison treatment). The capsules are taken once a week for four weeks, followed by an eight-week follow-up period.
- Listed locations
- Phoenix and 36 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Participation duration
- The treatment period is 4 weeks, followed by 8 weeks of follow-up.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 2, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 300
- Sponsor
- Transcend Therapeutics
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07456696
- Official title
Show the full official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Phoenix · Tucson · Little Rock
34 more locations
- Imperial
- La Jolla
- Los Angeles
- Montclair
- Oceanside
- Orange
- San Juan Capistrano
- Evergreen
- Jacksonville
- Lauderhill
- Maitland
- Orlando
- Atlanta
- Chicago
- New Orleans
- Pikesville
- Worcester
- Creve Coeur
- Saint Charles
- Cherry Hill
- Princeton
- Toms River
- New York
- Independence
- Plymouth Meeting
- West Chester
- Memphis
- Austin
- El Paso
- Houston
- Draper
- Orem
- Seattle
- Madison
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing TSND-201 and placebo to find out how the approaches affect post-traumatic stress symptoms in people with PTSD.
Who is behind this study?
The study sponsor is Transcend Therapeutics.
Does this study involve medication?
Yes. The study involves medication, including TSND-201 and Placebo.
Who can participate?
This study is for people with PTSD. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
